Karin Rotem-Wildeman

Karin Rotem-Wildeman

Chief Research & Development OfficeratKeurig Dr Pepper· In the 2023 proxy

Pay in FY2023Keurig Dr Pepper stock -6.6% the same year

Karin Rotem-Wildeman was paid $4.6M in FY2023 (Dec). Keurig Dr Pepper stock fell 6.6% that year.

Pay$100 in the stock at the end of FY22 → $93
Pay is from the Summary Compensation Table of each Keurig Dr Pepper proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Keurig Dr PepperPublic company · 3 yr
    • Chief Research & Development Officer2023 – Present · 3 yrStock in role -3%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?